RCKT
Rocket Pharmaceuticals Inc
Price:  
8.32 
USD
Volume:  
1,182,331.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RCKT WACC - Weighted Average Cost of Capital

The WACC of Rocket Pharmaceuticals Inc (RCKT) is 6.6%.

The Cost of Equity of Rocket Pharmaceuticals Inc (RCKT) is 6.70%.
The Cost of Debt of Rocket Pharmaceuticals Inc (RCKT) is 5.00%.

Range Selected
Cost of equity 5.40% - 8.00% 6.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 7.9% 6.6%
WACC

RCKT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.33 0.55
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.40% 8.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.02 0.02
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 7.9%
Selected WACC 6.6%